Zevra Therapeutics
ZVRA
ZVRA
71 hedge funds and large institutions have $41.6M invested in Zevra Therapeutics in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 60 → 71 (+11)
6.32% more ownership
Funds ownership: 17.75% → 24.07% (+6.3%)
Holders
71
Holding in Top 10
–
Calls
$2.71M
Puts
$1.93M
Top Buyers
| 1 | +$8.16M | |
| 2 | +$2.47M | |
| 3 | +$1.8M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$696K |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$1.91M | |
| 3 | -$1.02M | |
| 4 |
Millennium Management
New York
|
-$842K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$813K |